Download PDF
Pharmacopsychiatry 2005; 38(3): 125-127
DOI: 10.1055/s-2005-864123
Original Paper
© Georg Thieme Verlag KG Stuttgart · New York

Dyspepsia in Chronic Psychiatric Patients

E. J. Mookhoek1 , V. M. M. Meijs2 , A. J. M. Loonen1 , H. G. M. Leufkens2
  • 1DeltaBouman Psychiatric Teaching Hospital, Poortugaal, The Netherlands
  • 2Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, The Netherlands
Further Information

Publication History

Received: 5.1.2004 Revised: 2.7.2004

Accepted: 18.10.2004

Publication Date:
18 May 2005 (online)

Also available at
    Permissions and Reprints

Introduction: We report on dyspeptic complaints among patients hospitalized in the long-stay ward of a general psychiatric hospital. Methods: A representative sample of the patients was interviewed using a structured questionnaire. Results: Eighty percent of the patients reported one or more symptoms of dyspepsia, and 68 % reported symptoms of reflux-like dyspepsia. Conclusion: Significant positive associations were found for dyspepsia complaints and clozapine (OR = 3.4), laxatives (OR = 4.4), and heavy smoking (OR = 2.3).

References

  • 1 Boekema P J, vanDam-vanIsselt E F, Bots M L, Smout A JPM. Functional bowel symptoms in a general Dutch population and associations with common stimulants.  Neth J Med. 2001;  59(1) 23-30
    PubMedGoogle Scholar
  • 2 Haug T T, Wilhelmsen I, Berstad A, Ursin H. Life events and stress in patients with functional dyspepsia compared with patients with duodenal ulcer and healthy controls.  Scand J Gastroenterol. 1995;  30(6) 524-530
    PubMedGoogle Scholar
  • 3 Humphries T J, Merritt G J. Review article: drug interactions with agents used to treat acid-related diseases.  Aliment Pharmacol Ther. 1999;  13 (suppl 3) 18-26
    CrossrefPubMedGoogle Scholar
  • 4 John J P, Chengappa K N, Baker R W, Gupta B, Mortimer M T. Assesment of changes in both weight and frequency of use of medications for the treatment of gastrointestinal symptoms among clozapine-treated patients.  Ann Clin Psychiatry. 1995;  7(3) 119-125
    PubMedGoogle Scholar
  • 5 Lydiard R B, Greenwald S, Weisman M M, Johnson J, Drossman D A, Ballenger J C. Panic disorder and gastrointestinal symptoms: findings from the NIMH epidemiologic catchment area project.  Am J Psychiatry. 1994;  151 64-70
    PubMedGoogle Scholar
  • 6 Mookhoek E J, Huijgen J. Drug therapy for dyspepsia on the long-stay wards of a general psychiatric hospital (Medicatiegebruik voor maagklachten bij patiënten opgenomen op afdelingen voor langdurig verblijf in een algemeen psychiatrisch ziekenhuis).  Tijdschr Psych. 1999;  41 359-366
    PubMedGoogle Scholar
  • 7 Mookhoek E J, Loonen A JM. Retrospective evaluation of the effect of omeprazole on clozapine metabolism.  Pharmacy World & Science. 2004;  26 180-182
    PubMedGoogle Scholar
  • 8 North C S, Alpers D H, Thompson S J, Spitznagel E L. Gastrointestinal symptoms and psychiatric disorders in the general population - findings from NIMH epidemiologic catchment area project.  Dig Dis Sci. 1996;  41(4) 633-640
    CrossrefPubMedGoogle Scholar
  • 9 Penston J G, Pounder R E. A survey of dyspepsia in Great Britain.  Aliment Pharmacol Ther. 1996;  10 83-89
    PubMedGoogle Scholar
  • 10 Talley N J, McNeill D, Piper D W. Environmetal factors and chronic unexplained dyspepsia - association with acetaminophen but not other analgesics, alcohol, coffee, tea or smoking.  Dig Dis Sci. 1988;  33(6) 641-648
    PubMedGoogle Scholar
  • 11 Talley N J, Zinsmeister A R, Schleck C D, Melton LJ I II. Smoking, alcohol and analgesics in dyspepsia and among dyspepsia subgroups; lack of an association in a community.  Gut. 1994;  35(5) 619-624
    PubMedGoogle Scholar

E. J. Mookhoek

DeltaBouman Psychiatric Teaching Hospital

P.O.box 800

3170 DZ Poortugaal

The Netherlands

Phone: +31 10 5031313

Fax: +31 10 5031414

Email: ejmdpz@deltabouman.nl